CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Thousands, $ in Thousands		3 Months Ended
		Mar. 31, 2020	Mar. 31, 2019
Revenue
Total revenue		$ 247,285	$ 197,756
Expenses
Cost of revenue (exclusive of depreciation and amortization expenses presented separately below)	[1]	175,653	117,441
Claims expenses		23,667	37,757
Selling, general and administrative expenses	[1]	54,698	74,838
Depreciation and amortization expenses		16,138	14,266
Loss on disposal of assets		6,447	0
Change in fair value of contingent consideration and indemnification asset		(3,818)	100
Total operating expenses		272,785	244,402
Operating loss		(25,500)	(46,646)
Interest income		919	1,060
Interest expense		(6,285)	(3,562)
Impairment of equity method investments		(47,133)	0
Loss from equity method investees		(412)	(424)
Other income (expense), net		(71)	427
Loss before income taxes and non-controlling interests		(78,482)	(49,145)
Provision (benefit) for income taxes		270	(496)
Net loss		(78,752)	(48,649)
Net loss attributable to non-controlling interests		0	(1,910)
Net loss attributable to common shareholders of Evolent Health, Inc.		$ (78,752)	$ (46,739)
Loss per common share
Basic and diluted (in dollars per share)		$ (0.93)	$ (0.59)
Weighted-average common shares outstanding
Basic and diluted (in shares)		84,793	79,335
Comprehensive loss
Net loss		$ (78,752)	$ (48,649)
Other comprehensive loss, net of taxes, related to:
Foreign currency translation adjustment		(153)	24
Total comprehensive loss		(78,905)	(48,625)
Total comprehensive loss attributable to non-controlling interests		0	(1,910)
Total comprehensive loss attributable to common shareholders of Evolent Health, Inc.		(78,905)	(46,715)
Transformation services
Revenue
Total revenue	[1]	5,238	3,353
Platform and operations services
Revenue
Total revenue	[1]	209,900	147,292
Premiums
Revenue
Total revenue		$ 32,147	$ 47,111

[1] See Note 18 for amounts attributable to related parties included in these line items.